Two-dimensional Diode Research Articles

Evaluation of a planar diode matrix for SRS patient-specific QA in comparison with GAFchromic films.

We validate the routine use of a two-dimensional (2D) diode matrix for patient specific pre-treatment verification for Cyberknife (CK) stereotactic radiosurgery and to compare it with film dosimetry. A total of 46 patients were selected according to the most frequent diseases treated at our institution with the CK system, that is, brain metastases, meningiomas, spine metastases, and prostate tumors. All cases were evaluated with GAFChromic EBT-3 films and SRS MapCHECK for Fixed cone, IRIS, and MLC collimators of the CK. The highest mean passing rate was observed for the SRS MapCHECK system compared to films. In order to assess if the two techniques provide statistically different results, a Wilcoxon Signed-Rank non-parametric test was performed (p<0.05) and we found gamma values significantly lower for EBT-3 films with respect to the SRS MapCHECK. We noticed a moderately significant association between the two techniques using Spearman's rank correlation coefficient (rs>0.4). We also performed the Bland-Altman statistical method: less than 5% of the differences resulted outside the range (mean±1.96×SD), so the two methods can be considered interchangeable within the combined inaccuracy. The use of SRS MapCHECK for CK patient specific quality assurance (QA) is feasible for a variety of clinical districts and could be reliably used as a replacement for radiochromic films.

Blade-like field cathode with a dielectric coating mathematical modeling

In this paper the results of a two-dimensional diode emission system based on a blade-like field cathode in a polar coordinate system modeling is presented. The top of the emitter is a circle with a dielectric coating. The anode is a circle coaxial to the top of the emitter. The boundary condition of the first kind is set on the cathode, and the first and second kind on the anode. The problem of calculating the electrostatic potential distribution is reduced to solving a system of linear algebraic equations with constant coefficients. All the geometric dimensions of the system and the values of the potentials on the electrodes are the parameters of the problem.

Verification of Qfix Encompass™ couch modeling using the Acuros XB algorithm and HypeArc™ using a high-spatial-resolution two-dimensional diode array.

We modeled the Qfix Encompass™ immobilization system and further verified the calculated dose distribution of the AcurosXB (AXB) dose calculation algorithm using SRS MapCHECKⓇ (SRSMC) in the HyperArc™ (HA) clinical plan. An Encompass system with a StereoPHAN™ QA phantom was scanned by SOMATOM go.Sim and imported to an Eclipse™ treatment planning system to create a treatment plan for Encompass modeling. The Encompass modeling was performed in the StereoPHAN with a pinpoint ion chamber for 6 MV and 6 MV flattening filter free (6 MV FFF), and 2 × 2 cm2, 4 × 4 cm2, and 6 × 6 cm2 irradiation field sizes. The dose calculation algorithm used was AXB ver. 15.5 with a 1.0 mm calculation grid size. The Hounsfield unit (HU) values of the Encompass modeling were set to 400, -100, -200, and -300 for Encompass, and -400, -600, -700, and -800 for the Encompass base. We evaluated the dose distribution after Encompass modeling by SRSMC using gamma analysis in 12 patients. We adopted HU values of -200 for Encompass, -800 for Encompass base for 6 MV, and -200 for Encompass and -700 for Encompass. Base for 6 MV FFF was adopted as the HU values for the Encompass modeling based on the measurement results. The proposed Encompass modeling resulted in a mean pass rate evaluation >98% for both 6 MV and 6 MV FFF when the 1%/1 mm criterion was used, demonstrating that the proposed HU value can be adopted to calculate more accurate dose distributions.

Numerical simulation of a relativistic magnetron using a fluid electron model

An approach to numerically modeling relativistic magnetrons, in which the electrons are represented with a relativistic fluid, is described. A principal effect in the operation of a magnetron is space-charge-limited (SCL) emission of electrons from the cathode. We have developed an approximate SCL emission boundary condition for the fluid electron model. This boundary condition prescribes the flux of electrons as a function of the normal component of the electric field on the boundary. We show the results of a benchmarking activity that applies the fluid SCL boundary condition to the one-dimensional Child–Langmuir diode problem and a canonical two-dimensional diode problem. Simulation results for a two-dimensional A6 magnetron are then presented. Computed bunching of the electron cloud occurs and coincides with significant microwave power generation. Numerical convergence of the solution is considered. Sharp gradients in the solution quantities at the diocotron resonance, spanning an interval of three to four grid cells in the most well-resolved case, are present and likely affect convergence.

Impact of Dosimetric Parameters on Interplay Effects in 6 MV Flattening Filter-Free Photon Beams to Treat Lung Cancer.

Context:Interplay effects have become the significant problem in lung cancer radiotherapy. Since these effects yield dose variation within the target and surrounding tissues.Aim:The aim of this study is to investigate the effect of the dosimetric parameters of interplay effects in 6 MV flattening filter-free (FFF) photon beams for lung cancer.Settings and Design:This study performed planning, measurement, and data analysis sections for examining different breathing amplitudes and phases, doses, dose rates, field sizes, and fractionations.Subjects and Methods:Standard and clinical plans were created on the eclipse treatment planning system. The static and dynamic measurements were performed using a robotic platform and two-dimensional (2D) diode array. The gamma passing rates were defined as the percent of dose variation caused by the interplay effects.Statistical Analysis Used:Unpaired t-test.Results:The outcomes showed three trends between gamma passing rates (γ) and dosimetric parameters. First, a decreasing trend was breathing amplitudes. The lowest γ of maximum amplitudes (2 cm) in both one dimensional and 2D were <25%. Second, an increasing trend was field sizes. The lowest γ of minimum field size (4 cm × 4 cm2) was <55%. Third, constant outcomes were breathing phases, doses, dose rates, and a number of fractions. The γ values of these factors were 53.1%, 55.1%, 34.7%, and 36.7%, respectively.Conclusions:Lung tumor motion-induced interplay effects in 6 MV FFF photon beams are more pronounced for higher breathing amplitudes and smaller field sizes.

Evaluation of a two-dimensional diode array for patient-specific quality assurance of HyperArc.

PurposeTo evaluate a two‐dimensional diode array for patient‐specific quality assurance of VMAT stereotactic radiosurgery (SRS) plans.MethodsThe diode array, an SRS MapCHECK (SRSMC), was composed of a 77 mm ×77 mm face‐centered array having a spacing of 2.47 mm. Sixty SRS plans were selected from our clinical database, 30 for treatment of a single target and 30 for multiple targets. The target sizes ranged from 2.4 mm to 44.7 mm equivalent diameter (median 8.7 mm). The plans were delivered to the diode array. For multiple target plans, two measurements were obtained at two locations, one corresponding to the largest target and the other to the smallest target. Gamma using a 3%/1 mm criteria and the dose to the center diode were compared with radiochromic film (RCF). Dose to selected regions of the detector electronics was calculated.ResultsThe mean difference between the center diode and RCF was −1.2%. For a threshold of at least 95% of detectors/pixels having gamma < 1 for a 3%/1 mm criteria, SRSMC and RCF gave consistent results for 79 of the 90 measurements. For plans with an arc having a patient support angle of 90° or 270°, the median dose to the electronics was 0.65% of the prescription dose.ConclusionsSRSMC is an efficient tool for accurate patient‐specific quality assurance of VMAT single and multiple target radiosurgery, yielding similar clinical decisions as radiochromic film.

Dosimetric characterization of a new two-dimensional diode detector array used for stereotactic radiosurgery quality assurance

Dosimetric characterization of a new two-dimensional diode detector array used for stereotactic radiosurgery quality assurance

Dosimetric characterization of a new two-dimensional diode detector array used for stereotactic radiosurgery quality assurance

Dosimetric characterization of a new two-dimensional diode detector array used for stereotactic radiosurgery quality assurance

An in-plane WSe2 p–n homojunction two-dimensional diode by laser-induced doping

Laser-treatment was used to take p-doping effects on WSe2 locally, which induce in-plane WSe2 p–n homojunction.

Математическое моделирование двумерной диодной системы с полевым эмиттером лезвийной формы

In this paper the calculation of the electrostatic potential distribution for a two-dimensional diode emission system with a blade-shaped field emitter on a plane substrate is presented. The anode is a plane parallel to the substrate. To calculate the potential distribution, the effect of the emitter is simulated as the effect of a charged line, so that the emitter surface is zero equipotential. To solve the boundary problem, the method of separation of variables in Cartesian coordinates is used. All geometrical sizes of the diode system are parameters of the problem.

A Monte Carlo study on the feasibility of real-time in vivo source tracking during ultrasound based HDR prostate brachytherapy treatments

PurposeThis study aims to assess the accuracy of in-vivo source tracking during real-time trans-rectal ultrasound (TRUS) based high dose rate (HDR) prostate brachytherapy (pBT) through Monte Carlo simulations of multiple HDR pBT treatments with a two-dimensional (2D) diode array, the Magic Plate 900 (MP900), embedded below the patient in a carbon-fibre couch. MethodMonte Carlo simulations of source positions representing three separate real-time TRUS based HDR pBT treatments were performed using the Geant4 toolkit. For each source position, an Ir-192 source was simulated inside a voxelized patient geometry. Dose deposited from each source position to the MP900 diodes was used to perform source tracking, and the MP900 calculated position compared to known source positions from the treatment plan. Thresholding techniques were implemented to improve source tracking accuracy with the TRUS probe present. ResultsThe average three-dimensional source position reconstruction discrepancy was 11.9 ± 2.4 mm and 1.5 ± 0.3 mm with and without the TRUS probe, respectively. Thresholding techniques improved the source position reconstruction discrepancy in the presence of the TRUS probe to 1.8 ± 0.4 mm. ConclusionInclusion of the TRUS probe inside the patient negatively affects source tracking accuracy when using the MP900 diode array for HDR pBT verification. Modification of the source tracking algorithm using thresholding techniques improves source tracking in the presence of the TRUS probe, achieving similar accuracy as when the TRUS probe is not present. This study demonstrates that accurate in-vivo source tracking during real-time TRUS based HDR pBT is feasible using the Magic Plate system.

Evaluating the Impact of Various Parameters on the Gamma Index Values of 2D Diode Array in IMRT Verification.

Background:MapCHECK2 is a two-dimensional diode arrays planar dosimetry verification system. Dosimetric results are evaluated with gamma index. This study aims to provide comprehensive information on the impact of various factors on the gamma index values of MapCHECK2, which is mostly used for IMRT dose verification.Methods:Seven fields were planned for 6 and 18 MV photons. The azimuthal angle is defined as any rotation of collimators or the MapCHECK2 around the central axis, which was varied from 5 to −5°. The gantry angle was changed from −8 to 8°. Isodose sampling resolution was studied in the range of 0.5 to 4 mm. The effects of additional buildup on gamma index in three cases were also assessed. Gamma test acceptance criteria were 3%/3 mm.Results:The change of azimuthal angle in 5° interval reduced gamma index value by about 9%. The results of putting buildups of various thicknesses on the MapCHECK2 surface showed that gamma index was generally improved in thicker buildup, especially for 18 MV. Changing the sampling resolution from 4 to 2 mm resulted in an increase in gamma index by about 3.7%. The deviation of the gantry in 8° intervals in either directions changed the gamma index only by about 1.6% for 6 MV and 2.1% for 18 MV.Conclusion:Among the studied parameters, the azimuthal angle is one of the most effective factors on gamma index value. The gantry angle deviation and sampling resolution are less effective on gamma index value reduction.

Dosimetric Analysis on the Effect of Target Motion in the Delivery of Conventional IMRT, RapidArc and Tomotherapy

One of the methods to consider the effect of respiratory motion of a tumor target in radiotherapy is to establish a treatment plan with the internal target volume (ITV) created based on an accurate analysis of the target motion displacement. When this method is applied to intensity modulated radiotherapy (IMRT), it is expected to yield a different treatment dose distribution under the motion condition according to the IMRT method. In this study, we prepared ITV-based IMRT plans with conventional IMRT using fixed gantry angle beams, RapidArc using volumetric modulated arc therapy, and tomotherapy using helical therapy. Then, the variation in dose distribution caused by the target motion was analyzed by the dose measurement in the actual motion condition. A delivery quality assurance plan was prepared for the established IMRT plan and the dose distribution in the actual motion condition was measured and analyzed using a two-dimensional diode detector placed on a moving phantom capable of simulating breathing movements. The dose measurement was performed considering only a uniform target shape and motion in the superior-inferior (SI) direction. In this condition, it was confirmed that the error of the dose distribution due to the target motion is minimum in tomotherapy. This is thought to be due to the characteristic of tomotherapy that treats the target sequentially by dividing it into several slices. When the target shape is uniform and the main target motion direction is SI, it is considered that tomotherapy for the ITV-based IMRT method has a characteristic which can reduce the dose difference compared with the plan dose under the target motion condition.

Dosimetric characteristic of physical wedge versus enhanced dynamic wedge based on Monte Carlo simulations.

Physical wedges (PWs) are widely used in radiotherapy to obtain tilted isodose curves, but they alter beam quality. Dynamic wedges (DWs) using moving collimator overcome this problem, but measuring their beam data is not simple. The main aim of this study is to obtain all dosimetric parameters of DWs produced by Varian 2100CD with Monte Carlo simulation and compare them to those from PWs. To simulate 6 MV photon beams equipped with PW and DW, BEAMnrc code was used. All dosimetric data were obtained with EDR2 films and two-dimensional diode array detector. Good agreement between simulated and measured dosimetric data for PW and DW fields was obtained. Our results showed that percentage depth dose and beam profiles at nonwedged direction for DWs are the same as open fields and can be used to each other. From Monte Carlo simulations, it can be concluded that DWs in spite of PW do not have effect on beam quality and are good options for treatment planning system which cannot consider hardening effect produced by PWs. Furthermore, BEAMnrc is a powerful code to acquire all date required by DWs.

Dosimetric Characteristics of a Two-Dimensional Diode Array Detector Irradiated with Passively Scattered Proton Beams

Purpose: To evaluate the dosimetric characteristics of a two-dimensional (2D) diode array detector irradiated with passively scattered proton beams. Materials and Methods: A diode array detector, MapCHECK (Model 1175, Sun Nuclear, Melbourne, FL, USA) was characterized in passive-scattered proton beams. The relative sensitivity of the diodes and absolute dose calibration were determined using a 250 MeV beam. The pristine Bragg curves (PBCs) measured by MapCHECK diodes were compared with those of an ion chamber using a range shift method. The water-equivalent thickness (WET) of the diode array detector’s intrinsic buildup also was determined. The inverse square dependence, linearity, and other proton dosimetric quantities measured by MapCHECK were also compared with those of the ion chambers. The change in the absolute dose response of the MapCHECK as a function of accumulated radiation dose was used as an indicator of radiation damage to the diodes. 2D dose distribution with and without the compensator were measured and compared with the treatment planning system (TPS) calculations. Results: The WET of the MapCHECK diode’s buildup was determined to be 1.7 cm. The MapCHECK-measured PBC were virtually identical to those measured by a parallel-plate ion chamber for 160, 180, and 250 MeV proton beams. The inverse square results of the MapCHECK were within ±0.4% of the ion chamber results. The linearity of MapCHECK results was within 1% of those from the ion chamber as measured in the range between 10 and 300 MU. All other dosimetric quantities were within 1.3% of the ion chamber results. The 2D dose distributions for non-clinical fields without compensator and the patient treatment fields with the compensator were consistent with the TPS results. The absolute dose response of the MapCHECK was changed by 7.4% after an accumulated dose increased by 170 Gy. Conclusions: The MapCHECK is a convenient and useful tool for 2D dose distribution measurements using passively scattered proton beams. Variations in MapCHECK’s dose response with increasing levels of total accumulated radiation dose should be carefully monitored.

Development and validation of MCNPX-based Monte Carlo treatment plan verification system.

A Monte Carlo treatment plan verification (MCTPV) system was developed for clinical treatment plan verification (TPV), especially for the conformal and intensity-modulated radiotherapy (IMRT) plans. In the MCTPV, the MCNPX code was used for particle transport through the accelerator head and the patient body. MCTPV has an interface with TiGRT planning system and reads the information which is needed for Monte Carlo calculation transferred in digital image communications in medicine-radiation therapy (DICOM-RT) format. In MCTPV several methods were applied in order to reduce the simulation time. The relative dose distribution of a clinical prostate conformal plan calculated by the MCTPV was compared with that of TiGRT planning system. The results showed well implementation of the beams configuration and patient information in this system. For quantitative evaluation of MCTPV a two-dimensional (2D) diode array (MapCHECK2) and gamma index analysis were used. The gamma passing rate (3%/3 mm) of an IMRT plan was found to be 98.5% for total beams. Also, comparison of the measured and Monte Carlo calculated doses at several points inside an inhomogeneous phantom for 6- and 18-MV photon beams showed a good agreement (within 1.5%). The accuracy and timing results of MCTPV showed that MCTPV could be used very efficiently for additional assessment of complicated plans such as IMRT plan.

Dose-to-water conversion for the backscatter-shielded EPID: a frame-based method to correct for EPID energy response to MLC transmitted radiation.

To develop a frame-by-frame correction for the energy response of amorphous silicon electronic portal imaging devices (a-Si EPIDs) to radiation that has transmitted through the multileaf collimator (MLC) and to integrate this correction into the backscatter shielded EPID (BSS-EPID) dose-to-water conversion model. Individual EPID frames were acquired using a Varian frame grabber and iTools acquisition software then processed using in-house software developed inMATLAB. For each EPID image frame, the region below the MLC leaves was identified and all pixels in this region were multiplied by a factor of 1.3 to correct for the under-response of the imager to MLC transmitted radiation. The corrected frames were then summed to form a corrected integrated EPID image. This correction was implemented as an initial step in the BSS-EPID dose-to-water conversion model which was then used to compute dose planes in a water phantom for 35 IMRT fields. The calculated dose planes, with and without the proposed MLC transmission correction, were compared to measurements in solid water using a two-dimensional diode array. It was observed that the integration of the MLC transmission correction into the BSS-EPID dose model improved agreement between modeled and measured dose planes. In particular, the MLC correction produced higher pass rates for almost all Head and Neck fields tested, yielding an average pass rate of 99.8% for 2%/2 mm criteria. A two-sample independent t-test and fisher F-test were used to show that the MLC transmission correction resulted in a statistically significant reduction in the mean and the standard deviation of the gamma values, respectively, to give a more accurate and consistent dose-to-water conversion. The frame-by-frame MLC transmission response correction was shown to improve the accuracy and reduce the variability of the BSS-EPID dose-to-water conversion model. The correction may be applied as a preprocessing step in any pretreatment portal dosimetry calculation and has been shown to be beneficial for highly modulated IMRT fields.

DICOM-RT Plan Complexity Verification for Volumetric Modulated Arc Therapy

The purpose of this study was to investigate the relationship between plan parameters verified with DICOM-RT and dosimetric results for volumetric modulated arc therapy (VMAT). We investigated three treatment locations: prostate cancer (ten cases), maxillary sinus cancer (four cases), and malignant pleura mesothelioma (four cases) with treatment plans generated by a MonacoTM treatment planning system (TPS), and delivered with an Elekta SynergyTM linear accelerator. We calculated plan parameters, including gantry and multileaf collimator (MLC) positions, Monitor Units (MU), and millimeters of MLC motion per degree of gantry rotation (mm/degree), and performed quality assurance (QA) with a DICOM-RT plan verification system. We measured the VMAT dose with a two-dimensional diode array detector. The average gamma passing rate with percent dose acceptance criteria and distance to agreement criteria of 2 mm and 2% (2 mm/2%) were 97.4%, 97.8% and 92.0% for prostate cancer, maxillary sinus cancer, and malignant pleural mesothelioma, respectively. The mean 95th percentile value for DICOM-calculated mm/degree was 4.0, 5.2, and 11.1 for prostate cancer, maxillary sinus cancer, and malignant pleural mesothelioma, respectively. The gamma passing rate showed a correlation with calculated mm/degree, with a coefficient of determination (R2) of 0.60. Higher calculated mm/degree values led to increased dosimetric errors. We conclude that dose distribution calculated by a TPS is more reliable at smaller mm/degree.

Moderately converging ion and electron flows in two-dimensional diodes

Flow of particles in diodes is solved selfconsistently assuming an approximated system of flow lines, that can be easily represented by an analytic transformation in a complex plane, with assumed uniformity in the third spatial direction. Beam current compression is tunable by an angle parameter α(0); transformed coordinate lines are circular arcs, exactly matching to the curved cathode usually considered by rectilinear converging flows. The curvature of flow lines allows to partly balance the transverse effect of space charge. A self-contained discussion of the whole theory is reported, ranging from analytical solution for selfconsistent potential to electrode drawing to precise numerical simulation, which serves as a verification and as an illustration of typical electrode shapes. Motion and Poisson equation are written in a curved flow line system and their approximate consistency is shown to imply an ordinary differential equation for the beam edge potential. Transformations of this equation and their series solutions are given and discussed, showing that beam edge potential has a maximum, so supporting both diode (with α(0) =/~ π∕3) and triode design. Numerical simulations confirm the consistency of these solution. Geometrical details of diode design are discussed: the condition of a zero divergence beam, with the necessary anode lens effect included, is written and solved, as a function of beam compression; accurate relations for diode parameters and perveance are given. Weakly relativistic effects including self-magnetic field are finally discussed as a refinement.

Comparison of action levels for patient-specific quality assurance of intensity modulated radiation therapy and volumetric modulated arc therapy treatments

To perform a comprehensive and systematic comparison of fixed-beam IMRT and volumetric modulated arc therapy (VMAT) patient-specific QA measurements for a common set of geometries using typical measurement methods. Fixed-beam IMRT and VMAT plans were constructed for structure set geometries provided by AAPM Task Group 119. The plans were repeatedly delivered across multiple measurement sessions, and the resulting dose distributions were measured with (1) radiochromic film and ionization chamber and (2) a commercial two-dimensional diode array. The resulting QA measurements from each delivery technique were then analyzed, compared, and tested for statistically significant differences. Although differences were noted between QA results for some plans, neither modality showed consistently better agreement of measured and planned doses: of the 22 comparisons, IMRT showed better QA results in 11 cases, and VMAT showed better QA results in 11 cases. No statistically significant differences (p < 0.05) between IMRT and VMAT QA results were found for point doses measured with an ionization chamber, planar doses measured with radiochromic film, or planar doses measured with a two-dimensional diode array. These results suggest that it is appropriate to apply patient-specific QA action levels derived from fixed-beam IMRT to VMAT.